Mitochondrial Dysfunction and Metabolic Regulation of the Necroptosis Pathway in COPD and IPF
COPD 和 IPF 中坏死性凋亡途径的线粒体功能障碍和代谢调节
基本信息
- 批准号:10636900
- 负责人:
- 金额:$ 39.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-06 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:BleomycinCellsChronic Obstructive Pulmonary DiseaseChronic lung diseaseCigarette SmokerCigarette smoke-induced emphysemaComplexDataDevelopmentDisease MarkerDistalEpithelial CellsFatty-acid synthaseFibrosisFunctional disorderGenerationsGeneticIn VitroInjuryKidneyLinkLung diseasesMediatingMetabolicMetabolic PathwayMetabolismMitochondriaMitochondrial DNANecrosisOrganOrganellesOutcomePINK1 genePathogenesisPathway interactionsPatientsPhenotypePhosphotransferasesPlasmaPlayPre-Clinical ModelProcessProtein Kinase InteractionPublishingPulmonary EmphysemaPulmonary FibrosisRIPK1 geneReceptor ActivationRegulationRoleSeveritiesSeverity of illnessSignal TransductionStimulusTissuesUrinecell injurycigarette smokecigarette smoke-inducedcigarette smoke-induced lung diseasecigarette smoke-induced lung injuryclinical phenotypeexposure to cigarette smokeheteroplasmyhuman diseasein vivoindium-bleomycinlipid metabolismmitochondrial dysfunctionresponseurinary
项目摘要
Abstract
Fibrosis and emphysema represent divergent clinical phenotypes that emerge during the pathogenesis of chronic
lung diseases induced by cigarette smoke (CS). We have uncovered Udistinct mitochondrial and metabolic
pathways in response to injurious stimuli that may underlie divergent pathways leading to fibrosis or emphysema
outcomesU. Mitochondria are key organelles that regulate metabolism and energy generation, with complex
processes governing their dynamics (fusion, fission), and turnover (mitophagy). Mitochondrial dysfunction is an
emerging mechanism underlying the pathogenesis of many human diseases including COPD and IPF. We have
demonstrated that mitochondrial dysfunction mediates CS-induced epithelial cell injury/emphysema
development, and bleomycin (BLM)-induced pulmonary fibrosis; and interestingly, that genetic deficiency in the
critical mitophagy regulator PTEN-induced putative kinase-1 (PINK1) is UprotectiveU in preclinical models of CS-
induced emphysema while UdeleteriousU in BLM-induced pulmonary fibrosis. Moreover, PINK1-dependent
mitophagy was linked to the activation of receptor-interacting protein kinase-3 (RIPK3), a key signaling kinase
mediating regulated necrosis (necroptosis). We have published that RIPK3 regulates metabolic processes in
organ tissue, including (FA) biosynthetic pathways, and observed that genetic deficiency in fatty acid synthase
(FASN), aggravated pulmonary fibrosis. Interestingly, we have found that CS-induced lung injury may trigger
systemic responses including injury to distal organs (kidney). Moreover, we and others have found that
circulating cell-free (cf)-mtDNA, an established marker of mitochondrial injury and dysfunction, is regulated in
plasma or urine of COPD and IPF patients, and that cf-mtDNA sequence variability (heteroplasmy) may play
critical roles in the pathogenesis of lung diseases. These intriguing data suggest that mitochondrial pathways
influence functional and clinical phenotypes (fibrosis vs. emphysema) in response to CS exposure and led us to
propose the following Uhypotheses:U Mitochondrial dysfunction in response to CS can regulate pathways leading
to divergent phenotype in COPD or IPF, including the activation of PINK-dependent mitophagy and downstream
regulation of RIPK3. Furthermore, key metabolic and mitochondrial signals including mitochondrial fusion/fission
and lipid metabolism may determine cellular pathways leading to emphysema or fibrosis. Plasma and/or urinary
cf-mtDNA, as well as degree of mitochondrial heteroplasmy, may correlate with severity of IPF and COPD. We
will address our hypotheses in the following USpecific Aims:U Specific Aim 1: To determine the functional
significance of PINK1-regulated RIPK3 signaling in experimental emphysema and fibrosis. Specific Aim 2: To
determine the mechanism(s) by which mitochondrial and metabolic pathways regulate PINK1-RIPK3 signaling
in experimental emphysema and fibrosis. Specific Aim 3: To evaluate whether circulating or urinary cf-mtDNA is
associated with severity of disease in IPF and COPD.
摘要
纤维化和肺气肿代表了慢性肺纤维化发病过程中出现的不同临床表型,
吸烟引起的肺部疾病(CS)。我们发现了独特的线粒体和代谢
对可能导致纤维化或肺气肿的发散性通路基础的有害刺激作出反应的通路
outcomesU.线粒体是调节代谢和能量产生的关键细胞器,具有复杂的
控制其动力学(融合,裂变)和周转(线粒体自噬)的过程。线粒体功能障碍是一种
在许多人类疾病包括COPD和IPF的发病机制中,我们有
表明线粒体功能障碍介导CS诱导的上皮细胞损伤/肺气肿
发育和博莱霉素(BLM)诱导的肺纤维化;有趣的是,
关键的线粒体自噬调节因子PTEN诱导的推定激酶-1(PINK 1)在CS临床前模型中具有保护作用。
诱导的肺气肿,而在BLM诱导的肺纤维化中,PINK 1依赖
线粒体自噬与受体相互作用蛋白激酶3(RIPK 3)的激活有关,RIPK 3是一种关键的信号激酶,
介导调节性坏死(坏死性凋亡)。我们已经发表了RIPK 3调节代谢过程,
器官组织,包括(FA)生物合成途径,并观察到脂肪酸合成酶的遗传缺陷,
(FEV 1),肺纤维化加重。有趣的是,我们发现CS诱导的肺损伤可能引发
全身反应,包括对远端器官(肾脏)的损伤。此外,我们和其他人发现,
循环无细胞(cf)-线粒体DNA,一个确定的线粒体损伤和功能障碍的标志物,
COPD和IPF患者的血浆或尿液中,cf-mtDNA序列变异性(异质性)可能起作用,
在肺部疾病的发病机制中起关键作用。这些有趣的数据表明,
影响功能和临床表型(纤维化与肺气肿),并导致我们
提出以下假设:响应CS的线粒体功能障碍可以调节导致
COPD或IPF中的不同表型,包括PINK依赖性线粒体自噬和下游
RIPK 3的规则。此外,关键的代谢和线粒体信号,包括线粒体融合/分裂,
并且脂质代谢可以决定导致肺气肿或纤维化的细胞途径。血浆和/或尿液
cf-mtDNA以及线粒体异质性程度可能与IPF和COPD的严重程度相关。我们
我们将在以下USpecific目标中阐述我们的假设:USpecific目标1:确定功能
PINK 1调节RIPK 3信号在实验性肺气肿和纤维化中的意义具体目标2:
确定线粒体和代谢途径调节PINK 1-RIPK 3信号传导的机制
实验性肺气肿和纤维化具体目标3:评估循环或尿液cf-mtDNA是否是
与IPF和COPD的疾病严重程度相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Augustine M Choi其他文献
Augustine M Choi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Augustine M Choi', 18)}}的其他基金
A Phase 1b Study of Inhaled CO for the Treatment of Sepsis-Induced ARDS
吸入 CO 治疗脓毒症引起的 ARDS 的 1b 期研究
- 批准号:
10028004 - 财政年份:2020
- 资助金额:
$ 39.99万 - 项目类别:
Multidisciplinary Approach Training in Respiratory Research
呼吸研究多学科方法培训
- 批准号:
10348195 - 财政年份:2018
- 资助金额:
$ 39.99万 - 项目类别:
Multidisciplinary Approach Training in Respiratory Research
呼吸研究多学科方法培训
- 批准号:
10555619 - 财政年份:2018
- 资助金额:
$ 39.99万 - 项目类别:
Metabolic dysfunction regulates mitophagy-dependent necroptosis in COPD
代谢功能障碍调节 COPD 中线粒体自噬依赖性坏死性凋亡
- 批准号:
9566374 - 财政年份:2017
- 资助金额:
$ 39.99万 - 项目类别:
Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers
吸烟者纤维化和肺气肿的独特和重叠途径
- 批准号:
10172307 - 财政年份:2013
- 资助金额:
$ 39.99万 - 项目类别:
Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers
吸烟者纤维化和肺气肿的独特和重叠途径
- 批准号:
9300997 - 财政年份:2013
- 资助金额:
$ 39.99万 - 项目类别:
Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers
吸烟者纤维化和肺气肿的独特和重叠途径
- 批准号:
8476322 - 财政年份:2013
- 资助金额:
$ 39.99万 - 项目类别:
Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers
吸烟者纤维化和肺气肿的独特和重叠途径
- 批准号:
10636890 - 财政年份:2013
- 资助金额:
$ 39.99万 - 项目类别:
Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers
吸烟者纤维化和肺气肿的独特和重叠途径
- 批准号:
9113651 - 财政年份:2013
- 资助金额:
$ 39.99万 - 项目类别:
相似国自然基金
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
- 批准号:
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
- 批准号:82070825
- 批准年份:2020
- 资助金额:53 万元
- 项目类别:面上项目
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
- 批准号:81903002
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
- 批准号:81402419
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
- 批准号:81271563
- 批准年份:2012
- 资助金额:60.0 万元
- 项目类别:面上项目
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
- 批准号:31272541
- 批准年份:2012
- 资助金额:82.0 万元
- 项目类别:面上项目
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
- 批准号:31271248
- 批准年份:2012
- 资助金额:80.0 万元
- 项目类别:面上项目
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
- 批准号:81160050
- 批准年份:2011
- 资助金额:49.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Understanding Dysregulated Crosstalk Between Regulatory T Cells and Lung Dendritic Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease
了解慢性阻塞性肺疾病发病机制中调节性 T 细胞和肺树突状细胞之间的失调串扰
- 批准号:
10460830 - 财政年份:2022
- 资助金额:
$ 39.99万 - 项目类别:
Understanding Dysregulated Crosstalk Between Regulatory T Cells and Lung Dendritic Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease
了解慢性阻塞性肺疾病发病机制中调节性 T 细胞和肺树突状细胞之间的失调串扰
- 批准号:
10746742 - 财政年份:2022
- 资助金额:
$ 39.99万 - 项目类别:
Evaluation of mechanisms of increases in virus replication in bronchial epithelial cells from patients with chronic obstructive pulmonary disease
慢性阻塞性肺疾病患者支气管上皮细胞病毒复制增加机制的评估
- 批准号:
18K15953 - 财政年份:2018
- 资助金额:
$ 39.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Increased LHX9 expression in alveolar epithelial type 2 cells of patients with chronic obstructive pulmonary disease
慢性阻塞性肺疾病患者肺泡上皮2型细胞中LHX9表达增加
- 批准号:
18K08134 - 财政年份:2018
- 资助金额:
$ 39.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Role of Adenine Nucleotide Translocase in the Protection of Airway Epithelial Cells in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在保护慢性阻塞性肺疾病 (COPD) 气道上皮细胞中的作用
- 批准号:
10459434 - 财政年份:2018
- 资助金额:
$ 39.99万 - 项目类别:
The Role of Adenine Nucleotide Translocase in the Protection of Airway Epithelial Cells in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在保护慢性阻塞性肺疾病 (COPD) 气道上皮细胞中的作用
- 批准号:
10226893 - 财政年份:2018
- 资助金额:
$ 39.99万 - 项目类别:
The Role of Adenine Nucleotide Translocase in the Protection of Airway Epithelial Cells in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在保护慢性阻塞性肺疾病 (COPD) 气道上皮细胞中的作用
- 批准号:
9764469 - 财政年份:2018
- 资助金额:
$ 39.99万 - 项目类别:
Gene expresion analysis of lung endothelial cells in chronic obstructive pulmonary disease
慢性阻塞性肺疾病肺内皮细胞基因表达分析
- 批准号:
16K19438 - 财政年份:2016
- 资助金额:
$ 39.99万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Exploiting increased autophagy in bronchial epithelial cells: a new therapeutic approach for chronic obstructive pulmonary disease (COPD)
利用支气管上皮细胞自噬的增加:慢性阻塞性肺疾病(COPD)的新治疗方法
- 批准号:
nhmrc : 1099040 - 财政年份:2016
- 资助金额:
$ 39.99万 - 项目类别:
Project Grants
Exploiting increased autophagy in bronchial epithelial cells: a new therapeutic approach for chronic obstructive pulmonary disease (COPD)
利用支气管上皮细胞自噬的增加:慢性阻塞性肺疾病(COPD)的新治疗方法
- 批准号:
nhmrc : GNT1099040 - 财政年份:2016
- 资助金额:
$ 39.99万 - 项目类别:
Project Grants